{
  "retracted": false,
  "timestamp": 1578960000000,
  "updates": [
    {
      "timestamp": 1591727225190,
      "identifier": {
        "doi": "10.1038/s41375-020-0707-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41375-019-0413-0"
  },
  "journal": "Leukemia",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1"
}
